Buy Alembic Pharma; target of Rs 635: HDFC Securities News News / News 6 years ago 649 Views comments HDFC Securities is bullish on Alembic Pharma has recommended buy rating on the stock with a target price of Rs 635 in its research report dated July 2... Read more
News Amazon#39;s cash on delivery: Tech-giant#39;s investments show intent to capture Indian market News / News - 6 years ago
News Amazon Flipkart are not competitors to Paytm Mall, says COO Amit Sinha News / News - 6 years ago
Comments